Chronic Kidney Disease (CKD) is a progressive, irreversible
decline in kidney function occurring over months to years. Globally, CKD
affects nearly 10–15% of adults. In India, prevalence estimates range from
8–12%.
Definition and Classification: CKD is defined as
abnormalities of kidney structure or function present for more than 3 months.
Classified into 5 stages based on
a. Glomerular Filtration Rate (GFR): G1 to
G5, with G3 split into 3a and 3b
b. Subcategorized according to the spot urinary
albumin-creatinine ratio : 3 levels of albuminuria (A1, A2, and A3), with each
stage of CKD
CKD classification also recommends specifying the cause of
CKD (e.g., diabetic nephropathy, hypertensive nephrosclerosis)
Etiology
Diabetes Mellitus (Diabetic Nephropathy)
Hypertension (Hypertensive Nephrosclerosis)
Glomerulonephritis
Polycystic Kidney Disease
Obstructive Uropathy
Prolonged use of nephrotoxic drugs (NSAIDs, certain
antibiotics)
Risk factors:
Age >60 years
Family history of CKD
Cardiovascular disease
Obesity and metabolic syndrome
Smoking
Recurrent urinary tract infections
Low birth weight (predisposing to reduced nephron number)
Pathophysiology: CKD results from chronic and
sustained insults leading to a gradual loss of functioning nephrons. The
remaining nephrons undergo hyperfiltration to compensate, which increases
intraglomerular pressure. This intraglomerular hypertension in turn leads to
increased glomerular permeability and filtration resulting in proteinuria.
Increased tubular resorption of protein results in tubulointerstitial
inflammation & fibrosis. Over time, this leads to glomerulosclerosis, tubulointerstitial
fibrosis, vascular sclerosis and further nephron loss - a vicious cycle
culminating in end stage kidney disease (ESKD).
Clinical Features:
CKD often remains asymptomatic until advanced stages.
Symptoms do not appear till more than 50% kidney function is lost.
Early (nonspecific) manifestations:
Fatigue and malaise
Loss of appetite/ Nausea or
vomiting
Nocturia or polyuria
Mild edema
Late manifestations:
Generalized swelling
Shortness of breath
Generalised Pruritus
Cardiovascular manifestations-
Arrhythmias, Ischaemic heart disease.
Bone pain or fractures (renal
osteodystrophy)
Cognitive impairment or
drowsiness (uremic encephalopathy)
Diagnosis:
CKD is diagnosed through a combination of laboratory tests
and imaging studies.
Laboratory Evaluation:
a.
Serum Creatinine and eGFR: cornerstone for
staging kidney function.
b.
Urinalysis: to detect protein, sugars, RBC, WBC
or casts
c.
Urine Albumin Creatinine Ratio (UACR): quantify albuminuria,
an early marker.
d.
Serum Electrolytes: Na, K, Ca, Phosphorus
e.
iPTH, Sr HCO3-
f.
Hemoglobin
g.
Lipid profile: to assess metabolic risk factors
h.
HbA1c: to assess degree of blood sugar control.
Imaging Studies:
a.
Ultrasonography: to check size, alteration in
echogenicity & corticomedullary differentiation, to detect obstruction etc.
b.
CT/MRI: in selected cases to evaluate structure
or vascular causes.
Renal Biopsy: Indicated when the cause is uncertain
or glomerulonephritis is suspected.
Complications: CKD is a systemic disorder with
multiple complications:
1.
Cardiovascular disease: present in approx. 75%
patients.
2.
Anemia
3.
Mineral and Bone Disorder (CKD-MBD
4.
Metabolic acidosis
5.
Electrolyte disturbances: hyperkalemia,
hyperphosphatemia, hypocalcemia.
6.
Fluid overload
7.
Uremic complications: pericarditis,
encephalopathy, neuropathy.
Management: The goals of CKD management are to treat the underlying
disease, slow disease progression, treat complications, and prepare for renal
replacement therapy.
Treat the Underlying Cause:
1.
Glycemic control: maintain HbA1c <7%.
2.
Blood pressure control: target <130/80 mmHg.
3.
Control of proteinuria
4.
Avoid nephrotoxic drugs: NSAIDs, contrast
agents, and certain antibiotics.
Lifestyle Modifications:
1.
Dietary salt restriction (3-5 g/day).
2.
Moderate protein intake (0.8 g/kg/day).
3.
Maintain ideal body weight.
4.
Avoid smoking and alcohol.
5.
Encourage regular physical activity.
Prepare for Renal Replacement Therapy: Options
include
1.
Hemodialysis,
2.
Peritoneal dialysis
3.
Kidney transplantation
Prognosis: The prognosis depends on the stage at diagnosis and
control of underlying conditions. Earlier diagnosis helps prevent further
damage to kidneys and also slow down progression of disease. Patients with well
controlled diabetes and blood pressure can stabilize for years. Newer
medications to slow progression of kidney damage can help improve outcomes. In
patients with End Stage Kidney disease kidney transplant is the renal
replacement therapy of choice.